...
首页> 外文期刊>European journal of pharmaceutical sciences >Formulation and in vivo human bioavailability of dissolving tablets containing a self-nanoemulsifying itraconazole solid dispersion without precipitation in simulated gastrointestinal fluid
【24h】

Formulation and in vivo human bioavailability of dissolving tablets containing a self-nanoemulsifying itraconazole solid dispersion without precipitation in simulated gastrointestinal fluid

机译:含有自纳米乳化伊曲康唑固体分散体但在模拟胃肠液中无沉淀的溶解片剂的制剂和体内人体内生物利用度

获取原文
获取原文并翻译 | 示例
           

摘要

Solid dispersion (SD), which is defined as the dispersion of one or more active ingredients in an inert hydrophilic carrier or matrix, is commonly used to improve the dissolution rate of various poorly water-soluble drugs because of its simplicity and ease of manufac-turability (Heo et al., 2005; Park et al., 2007). However, conventional SD requires various pharmaceutical excipients, such as solubilisers, surfactants, oils and fatty acids, or mixtures of these aforementioned excipients to overcome the limited solubilising enhancement of SD alone (Heo et al., 2005; Shim et al., 2006; Park et al., 2007). In contrast, self-emulsifying or self-microemulsifying drug delivery systems can also be successfully used to improve the oral bioavailability of poorly water-soluble drugs and are normally prepared as liquids (Attama et al., 2003; Franceschinisa et al., 2005; Shim et al., 2006; Park et al., 2007; Woo et al., 2008).
机译:固体分散体(SD)定义为一种或多种活性成分在惰性亲水性载体或基质中的分散体,由于其简单性和易加工性,通常用于提高各种水溶性差的药物的溶出度。 (Heo et al。,2005; Park et al。,2007)。然而,常规SD需要各种药物赋形剂,例如增溶剂,表面活性剂,油和脂肪酸,或上述这些赋形剂的混合物,以克服单独SD对有限的增溶作用(Heo et al。,2005; Shim et al。,2006; Park等,2007)。相反,自乳化或自微乳化的药物递送系统也可以成功地用于改善水溶性差的药物的口服生物利用度,并且通常以液体形式制备(Attama等,2003; Franceschinisa等,2005; Attama等,2003)。 Shim等,2006; Park等,2007; Woo等,2008)。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号